Enovis Corp. (ENOV)
24.29
-1.83
(-7.01%)
USD |
NYSE |
May 15, 16:00
24.30
+0.01
(+0.04%)
After-Hours: 20:00
Enovis EPS Diluted (Quarterly) : -0.1529 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.06 |
| Globus Medical, Inc. | 0.8995 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
| Accuray, Inc. | -0.095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.411M |
| Revenue (Quarterly) | 589.15M |
| Total Expenses (Quarterly) | 597.88M |
| Enterprise Value | 2.778B |
| Gross Profit Margin (Quarterly) | 54.92% |
| Profit Margin (Quarterly) | -1.43% |
| Earnings Yield | -81.76% |
| Operating Earnings Yield | 3.75% |
| Normalized Earnings Yield | -24.98 |